Pharma & Healthcare
Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 09, 25
- ID: 430849
- Pages: 97
- Figures: 92
- Views: 3
The global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
5-HT3 Inhibitors
NK1 Inhibitors
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Acute CINV
Delayed CINV
Breakthrough CINV
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Heron Therapeutics in Europe)
- Emerging Product Trends: 5-HT3 Inhibitors adoption vs. NK1 Inhibitors premiumization
- Demand-Side Dynamics: Acute CINV growth in China vs. Delayed CINV potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., NK1 Inhibitors in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Delayed CINV in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 5-HT3 Inhibitors dominance in Europe vs. NK1 Inhibitors demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
Heron Therapeutics
Merck
Eisai
Mundipharma
Qilu Pharma
Teva
Novartis
Roche
Mylan
Baxter
GSK
Helsinn
Southwest Pharma
Haisco
Sun Pharma
By Type: (Dominant Segment vs High-Margin Innovation)
5-HT3 Inhibitors
NK1 Inhibitors
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Acute CINV
Delayed CINV
Breakthrough CINV
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Heron Therapeutics in Europe)
- Emerging Product Trends: 5-HT3 Inhibitors adoption vs. NK1 Inhibitors premiumization
- Demand-Side Dynamics: Acute CINV growth in China vs. Delayed CINV potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., NK1 Inhibitors in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Delayed CINV in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., 5-HT3 Inhibitors dominance in Europe vs. NK1 Inhibitors demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Scope
1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type
1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020 & 2024 & 2031)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application
1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Acute CINV
1.3.3 Delayed CINV
1.3.4 Breakthrough CINV
1.3.5 Others
1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts (2020-2031)
1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2020-2025)
2.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2020-2025)
2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.4 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.5 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Review by Type (2020-2025)
3.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025)
3.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2020-2025)
3.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2020-2025)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2026-2031)
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2026-2031)
3.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Type (2026-2031)
3.3 Different Types Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Representative Players
4 Global Market Size by Application
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Review by Application (2020-2025)
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2020-2025)
4.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2020-2025)
4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2026-2031)
4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2026-2031)
4.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Application
5 Competition Landscape by Players
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Players (2020-2025)
5.2 Global Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players by Revenue (2020-2025)
5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2024)
5.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
5.7 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.1.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.1.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.1.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.1.4 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.2.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.2.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.2.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.2.4 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.3.1.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.3.1.2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.3.2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.3.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.3.4 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.4.1.1 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.4.1.2 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.4.2 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.4.3 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.4.4 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.5.1.1 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.5.1.2 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.5.2 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.5.3 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.5.4 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Heron Therapeutics
7.1.1 Heron Therapeutics Company Information
7.1.2 Heron Therapeutics Business Overview
7.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.1.5 Heron Therapeutics Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Business Overview
7.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.2.5 Merck Recent Development
7.3 Eisai
7.3.1 Eisai Company Information
7.3.2 Eisai Business Overview
7.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.3.5 Eisai Recent Development
7.4 Mundipharma
7.4.1 Mundipharma Company Information
7.4.2 Mundipharma Business Overview
7.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.4.5 Mundipharma Recent Development
7.5 Qilu Pharma
7.5.1 Qilu Pharma Company Information
7.5.2 Qilu Pharma Business Overview
7.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.5.5 Qilu Pharma Recent Development
7.6 Teva
7.6.1 Teva Company Information
7.6.2 Teva Business Overview
7.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.6.5 Teva Recent Development
7.7 Novartis
7.7.1 Novartis Company Information
7.7.2 Novartis Business Overview
7.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.7.5 Novartis Recent Development
7.8 Roche
7.8.1 Roche Company Information
7.8.2 Roche Business Overview
7.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.8.5 Roche Recent Development
7.9 Mylan
7.9.1 Mylan Company Information
7.9.2 Mylan Business Overview
7.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.9.5 Mylan Recent Development
7.10 Baxter
7.10.1 Baxter Company Information
7.10.2 Baxter Business Overview
7.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.10.5 Baxter Recent Development
7.11 GSK
7.11.1 GSK Company Information
7.11.2 GSK Business Overview
7.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.11.5 GSK Recent Development
7.12 Helsinn
7.12.1 Helsinn Company Information
7.12.2 Helsinn Business Overview
7.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.12.5 Helsinn Recent Development
7.13 Southwest Pharma
7.13.1 Southwest Pharma Company Information
7.13.2 Southwest Pharma Business Overview
7.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.13.5 Southwest Pharma Recent Development
7.14 Haisco
7.14.1 Haisco Company Information
7.14.2 Haisco Business Overview
7.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.14.5 Haisco Recent Development
7.15 Sun Pharma
7.15.1 Sun Pharma Company Information
7.15.2 Sun Pharma Business Overview
7.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.15.5 Sun Pharma Recent Development
8 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Cost Analysis
8.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
8.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
9.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Dynamics
10.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
10.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
10.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
10.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Scope
1.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Type
1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020 & 2024 & 2031)
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Application
1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Acute CINV
1.3.3 Delayed CINV
1.3.4 Breakthrough CINV
1.3.5 Others
1.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts (2020-2031)
1.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2020-2025)
2.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2020-2025)
2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.4 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
2.4.5 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Review by Type (2020-2025)
3.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025)
3.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2020-2025)
3.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2020-2025)
3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2026-2031)
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2026-2031)
3.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Type (2026-2031)
3.3 Different Types Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Representative Players
4 Global Market Size by Application
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Review by Application (2020-2025)
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2020-2025)
4.1.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2020-2025)
4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2026-2031)
4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2026-2031)
4.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Application
5 Competition Landscape by Players
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Players (2020-2025)
5.2 Global Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players by Revenue (2020-2025)
5.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2024)
5.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
5.7 Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.1.1.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.1.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.1.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.1.3 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.1.4 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.2.1.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.2.1.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.2.3 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.2.4 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.3.1.1 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.3.1.2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.3.2 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.3.3 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.3.4 China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.4.1.1 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.4.1.2 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.4.2 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.4.3 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.4.4 Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments, Downstream and Major Customers
6.5.1 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company
6.5.1.1 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025)
6.5.1.2 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025)
6.5.2 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Type (2020-2025)
6.5.3 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Breakdown by Application (2020-2025)
6.5.4 India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Major Customer
6.5.5 India Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Heron Therapeutics
7.1.1 Heron Therapeutics Company Information
7.1.2 Heron Therapeutics Business Overview
7.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.1.5 Heron Therapeutics Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Business Overview
7.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.2.5 Merck Recent Development
7.3 Eisai
7.3.1 Eisai Company Information
7.3.2 Eisai Business Overview
7.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.3.5 Eisai Recent Development
7.4 Mundipharma
7.4.1 Mundipharma Company Information
7.4.2 Mundipharma Business Overview
7.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.4.5 Mundipharma Recent Development
7.5 Qilu Pharma
7.5.1 Qilu Pharma Company Information
7.5.2 Qilu Pharma Business Overview
7.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.5.5 Qilu Pharma Recent Development
7.6 Teva
7.6.1 Teva Company Information
7.6.2 Teva Business Overview
7.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.6.5 Teva Recent Development
7.7 Novartis
7.7.1 Novartis Company Information
7.7.2 Novartis Business Overview
7.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.7.5 Novartis Recent Development
7.8 Roche
7.8.1 Roche Company Information
7.8.2 Roche Business Overview
7.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.8.5 Roche Recent Development
7.9 Mylan
7.9.1 Mylan Company Information
7.9.2 Mylan Business Overview
7.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.9.5 Mylan Recent Development
7.10 Baxter
7.10.1 Baxter Company Information
7.10.2 Baxter Business Overview
7.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.10.5 Baxter Recent Development
7.11 GSK
7.11.1 GSK Company Information
7.11.2 GSK Business Overview
7.11.3 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.11.4 GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.11.5 GSK Recent Development
7.12 Helsinn
7.12.1 Helsinn Company Information
7.12.2 Helsinn Business Overview
7.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.12.5 Helsinn Recent Development
7.13 Southwest Pharma
7.13.1 Southwest Pharma Company Information
7.13.2 Southwest Pharma Business Overview
7.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.13.5 Southwest Pharma Recent Development
7.14 Haisco
7.14.1 Haisco Company Information
7.14.2 Haisco Business Overview
7.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.14.5 Haisco Recent Development
7.15 Sun Pharma
7.15.1 Sun Pharma Company Information
7.15.2 Sun Pharma Business Overview
7.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
7.15.5 Sun Pharma Recent Development
8 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Cost Analysis
8.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
8.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
9.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
10 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Dynamics
10.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
10.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
10.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
10.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Region (2020-2025)
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2020-2025)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Region (2020-2025)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share Forecast by Region (2026-2031)
Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (M Units) & (2020-2025)
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2020-2025)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (M Units) & (2026-2031)
Table 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (M Units) & (2020-2025)
Table 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2020-2025)
Table 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (M Units) & (2026-2031)
Table 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Application
Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (M Units) & (2020-2025)
Table 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Company (2020-2025)
Table 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Company (2020-2025)
Table 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2024)
Table 33. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 39. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 40. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 42. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 43. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 44. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 45. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 46. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 47. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 48. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 50. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 51. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 53. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 54. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 55. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 56. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 58. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 59. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 60. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 61. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 62. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 63. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 64. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 66. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 67. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 68. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 69. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 70. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 71. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 72. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 74. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 75. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 76. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 77. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 78. Heron Therapeutics Company Information
Table 79. Heron Therapeutics Description and Business Overview
Table 80. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 82. Heron Therapeutics Recent Development
Table 83. Merck Company Information
Table 84. Merck Description and Business Overview
Table 85. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 87. Merck Recent Development
Table 88. Eisai Company Information
Table 89. Eisai Description and Business Overview
Table 90. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 92. Eisai Recent Development
Table 93. Mundipharma Company Information
Table 94. Mundipharma Description and Business Overview
Table 95. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 97. Mundipharma Recent Development
Table 98. Qilu Pharma Company Information
Table 99. Qilu Pharma Description and Business Overview
Table 100. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 102. Qilu Pharma Recent Development
Table 103. Teva Company Information
Table 104. Teva Description and Business Overview
Table 105. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 107. Teva Recent Development
Table 108. Novartis Company Information
Table 109. Novartis Description and Business Overview
Table 110. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 112. Novartis Recent Development
Table 113. Roche Company Information
Table 114. Roche Description and Business Overview
Table 115. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 117. Roche Recent Development
Table 118. Mylan Company Information
Table 119. Mylan Description and Business Overview
Table 120. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 122. Mylan Recent Development
Table 123. Baxter Company Information
Table 124. Baxter Description and Business Overview
Table 125. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 127. Baxter Recent Development
Table 128. GSK Company Information
Table 129. GSK Description and Business Overview
Table 130. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 132. GSK Recent Development
Table 133. Helsinn Company Information
Table 134. Helsinn Description and Business Overview
Table 135. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 137. Helsinn Recent Development
Table 138. Southwest Pharma Company Information
Table 139. Southwest Pharma Description and Business Overview
Table 140. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 142. Southwest Pharma Recent Development
Table 143. Haisco Company Information
Table 144. Haisco Description and Business Overview
Table 145. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 147. Haisco Recent Development
Table 148. Sun Pharma Company Information
Table 149. Sun Pharma Description and Business Overview
Table 150. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 152. Sun Pharma Recent Development
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 156. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List
Table 157. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Trends
Table 158. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
Table 159. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
Table 160. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Picture
Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. 5-HT3 Inhibitors Product Picture
Figure 5. NK1 Inhibitors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2024 & 2031
Figure 9. Acute CINV Examples
Figure 10. Delayed CINV Examples
Figure 11. Breakthrough CINV Examples
Figure 12. Others Examples
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 17. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Report Years Considered
Figure 18. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 22. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 24. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 26. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 28. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2020-2025)
Figure 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2026-2031)
Figure 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2026-2031)
Figure 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2020-2025)
Figure 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2026-2031)
Figure 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2026-2031)
Figure 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Company (2024)
Figure 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Company (2024)
Figure 39. Global 5 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs: 2020 & 2024
Figure 40. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 42. Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 43. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Region (2020-2025)
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2020-2025)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Region (2020-2025)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Forecast by Region (2026-2031)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share Forecast by Region (2026-2031)
Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (M Units) & (2020-2025)
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2020-2025)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (US$/Unit) & (2020-2025)
Table 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (M Units) & (2026-2031)
Table 17. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (US$/Unit) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (M Units) & (2020-2025)
Table 21. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2020-2025)
Table 22. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (US$/Unit) & (2020-2025)
Table 24. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (M Units) & (2026-2031)
Table 25. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (US$/Unit) & (2026-2031)
Table 27. New Sources of Growth in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Application
Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (M Units) & (2020-2025)
Table 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Company (2020-2025)
Table 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Company (2020-2025)
Table 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2024)
Table 33. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Price by Company (US$/Unit) & (2020-2025)
Table 34. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 39. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 40. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 42. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 43. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 44. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 45. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 46. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 47. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 48. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 50. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 51. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 52. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 53. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 54. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 55. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 56. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 58. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 59. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 60. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 61. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 62. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 63. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 64. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 66. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 67. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 68. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 69. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 70. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Company (2020-2025) & (M Units)
Table 71. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Company (2020-2025)
Table 72. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 73. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Company (2020-2025)
Table 74. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2020-2025) & (M Units)
Table 75. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2020-2025)
Table 76. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2020-2025) & (M Units)
Table 77. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2020-2025)
Table 78. Heron Therapeutics Company Information
Table 79. Heron Therapeutics Description and Business Overview
Table 80. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 82. Heron Therapeutics Recent Development
Table 83. Merck Company Information
Table 84. Merck Description and Business Overview
Table 85. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 86. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 87. Merck Recent Development
Table 88. Eisai Company Information
Table 89. Eisai Description and Business Overview
Table 90. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 91. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 92. Eisai Recent Development
Table 93. Mundipharma Company Information
Table 94. Mundipharma Description and Business Overview
Table 95. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 97. Mundipharma Recent Development
Table 98. Qilu Pharma Company Information
Table 99. Qilu Pharma Description and Business Overview
Table 100. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 101. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 102. Qilu Pharma Recent Development
Table 103. Teva Company Information
Table 104. Teva Description and Business Overview
Table 105. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 106. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 107. Teva Recent Development
Table 108. Novartis Company Information
Table 109. Novartis Description and Business Overview
Table 110. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 111. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 112. Novartis Recent Development
Table 113. Roche Company Information
Table 114. Roche Description and Business Overview
Table 115. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 116. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 117. Roche Recent Development
Table 118. Mylan Company Information
Table 119. Mylan Description and Business Overview
Table 120. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 121. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 122. Mylan Recent Development
Table 123. Baxter Company Information
Table 124. Baxter Description and Business Overview
Table 125. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 126. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 127. Baxter Recent Development
Table 128. GSK Company Information
Table 129. GSK Description and Business Overview
Table 130. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 131. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 132. GSK Recent Development
Table 133. Helsinn Company Information
Table 134. Helsinn Description and Business Overview
Table 135. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 136. Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 137. Helsinn Recent Development
Table 138. Southwest Pharma Company Information
Table 139. Southwest Pharma Description and Business Overview
Table 140. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 141. Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 142. Southwest Pharma Recent Development
Table 143. Haisco Company Information
Table 144. Haisco Description and Business Overview
Table 145. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 146. Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 147. Haisco Recent Development
Table 148. Sun Pharma Company Information
Table 149. Sun Pharma Description and Business Overview
Table 150. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 151. Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 152. Sun Pharma Recent Development
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Distributors List
Table 156. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers List
Table 157. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Trends
Table 158. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
Table 159. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
Table 160. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Picture
Figure 2. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. 5-HT3 Inhibitors Product Picture
Figure 5. NK1 Inhibitors Product Picture
Figure 6. Others Product Picture
Figure 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application in 2024 & 2031
Figure 9. Acute CINV Examples
Figure 10. Delayed CINV Examples
Figure 11. Breakthrough CINV Examples
Figure 12. Others Examples
Figure 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Growth Rate (2020-2031) & (US$ Million)
Figure 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 16. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Trends Growth Rate (2020-2031) & (US$/Unit)
Figure 17. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Report Years Considered
Figure 18. Global Market Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 22. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 24. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. China Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 26. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Japan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 28. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. India Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) Growth Rate (2020-2031)
Figure 30. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2020-2025)
Figure 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2026-2031)
Figure 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2026-2031)
Figure 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2020-2025)
Figure 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Growth Rate by Application in 2020 & 2024
Figure 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2026-2031)
Figure 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2026-2031)
Figure 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Company (2024)
Figure 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Company (2024)
Figure 39. Global 5 Largest Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players Market Share by Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs: 2020 & 2024
Figure 40. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 41. Manufacturing Cost Structure of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 42. Manufacturing Process Analysis of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs
Figure 43. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industrial Chain
Figure 44. Channels of Distribution (Direct Vs Distribution)
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232